Published: May 7th 2024 | Updated: May 21st 2024
FDA accepts BLA for subcutaneous nivolumab in solid tumors
Published: June 18th 2024 | Updated: October 22nd 2024
Cretostimogene grenadenorepvec made available through expanded access program
Published: October 7th 2024 | Updated: October 22nd 2024
Innovations in NMIBC Treatment: The Synergy of BCG and PD-1/PD-L1 Inhibitors
Published: October 7th 2024 | Updated: October 22nd 2024
Exploring PD-1/PD-L1 Pathways and Innovative Treatments for NMIBC
Published: September 30th 2024 | Updated: October 22nd 2024
NMIBC Treatment Insights: Standard of Care, BCG Immune Response, and Patient Outcomes
Published: September 30th 2024 | Updated: October 22nd 2024
Exploring NMIBC: Overview, Symptoms, Risk Factors and Staging